Eric Kuklinski, clinical research coordinator at Mount Sinai in New York, NY, discusses the methodology behind the Dry Eye Assessment and Management Study (DREAM) study and its findings at ARVO 2018 in Honolulu.
Dry eye plagues many patients who come into optometry practices, but some ODs struggle to provide the proper treatment. Scott Schachter, OD, gives his recommendations to help ODs begin to provide dry eye services at their practice.
A new study shows that omega-3 supplements offer the same benefits as the study's placebo, olive oil. Researchers and other experts discuss trial results and what's next for ODs treating dry eye.
Corneal filaments frequently recur after removal, and resolution occurs only by treating the patient’s underlying inflammation. This case illustrates the need to move to atypical therapies, such as N-acetylcysteine.
Patients present with contact lens discomfort for a variety of reasons. Mile Brujic, OD, FAAO, and David Kading, OD, FAAO, FCLSA, explain why proper lid hygiene may be the key to increasing contact lens comfort.
Many patients present with dry eye, and some ODs aren’t sure how to jump into the game. Scott Schachter, OD, offers his tips on expanding or incorporating dry eye services into your practice.
Demodex has been associated with inflammation of the lid margin and eyelash loss in patients. Take a closer look at mites and microorganisms to consider if, in moderation, they may be beneficial.
In Part 2 of her three-part series on cosmetic dangers, Tracy Schroeder-Swartz, OD, MS, FAAO, focuses on the dangers found in cosmetics—particularly cosmetics banned by the FDA and those that may exacerbate ocular surface disease.
Comprehensive ocular examinations can provide an OD with an inside look into a patient's health. Mile Brujic, OD, and David Kading, OD, discuss the importance of using upper eyelid eversion during the exam to unleash significant information about a patient's ocular surface and systemic health.
Michael Cooper, OD, takes a look at how the Japanese treat allergic conjunctivitis to gain a different perspective on treatments. What he finds is that we aren't so different after all.